Overview

Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is a study to establish the equivalence of OT329 Solis and Advair Diskus when administered by inhalation in patients with asthma.
Phase:
Phase 1
Details
Lead Sponsor:
Oriel Therapeutics
Treatments:
Fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone-Salmeterol Drug Combination
Salmeterol Xinafoate
Xhance